Volume 8, Issue 5, September 2020, Page: 221-225
Value of PET/CT and MATLAB in Detection of COVID-19 in an Oncology Patient - Case Report
Michael Masoomi, Nuclear Medicine and Molecular Imaging Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Alshaima Al-Shammeri, Nuclear Medicine and Molecular Imaging Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Esraa Al-Qattan, Nuclear Medicine and Molecular Imaging Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Haytham Ramzy, Radiology Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Hany A Elrahman, Nuclear Medicine and Molecular Imaging Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Aisha Al-Qattan, Nuclear Medicine and Molecular Imaging Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Latifah Al-Kandari, Radiology Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Iman Al-Shammeri, Nuclear Medicine and Molecular Imaging Section, Department of Medical Imaging, ADAN Hospital, Ministry of Health, Hadiya, Kuwait
Received: Jul. 24, 2020;       Accepted: Aug. 10, 2020;       Published: Aug. 25, 2020
DOI: 10.11648/j.ajim.20200805.15      View  105      Downloads  104
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the infectious disease COVID-19, was declared a global pandemic in March 2020. The SARS-CoV-2 infection has polymorphic clinical presentations. The real time PCR is the reference diagnostic test; however, it can only detect the presence of virus for a specific window of time and its sensitivity has been reported as low as 60–70%. Case: We report a clinical case for a 28-year-old male patient. His clinical history included known NHL (large B-cell lymphoma) that treated with chemotherapy and autologous bone marrow transplant in 2017. He initially presented with fewer, URTI (upper respiratory infection) and weight loss to have a PET/CT scan for restaging. The follow up PET/CT scan, suggested no worrisome FDG metabolic activity elsewhere to suggest disease recurrence, though, hypermetabolic mediastinal lymph nodes, which were kept with active infectious process and bilateral FDG-avid ground glass attenuation in between the consolidation patches were noted. The follow up RT-PCR post PET/CT scan was proved to be positive. A developed pixelated quantitative map of CT part of the lung using MATLAB showed clearly severity of the lung disease that strongly suggested COVID-19 lung in association with the positive RT-PCR. FDG PET/CT has the potential to add value to the challenges of diagnosing complications caused by viruses such as COVID-19.
Keywords
PET/CT, MATLAB, COVID-19, Oncology Patient
To cite this article
Michael Masoomi, Alshaima Al-Shammeri, Esraa Al-Qattan, Haytham Ramzy, Hany A Elrahman, Aisha Al-Qattan, Latifah Al-Kandari, Iman Al-Shammeri, Value of PET/CT and MATLAB in Detection of COVID-19 in an Oncology Patient - Case Report, American Journal of Internal Medicine. Vol. 8, No. 5, 2020, pp. 221-225. doi: 10.11648/j.ajim.20200805.15
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it (Accessed 03/22/2020).
[2]
Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. https://doi.org/10.1101/2020.02.07.937862 doi: bioRxiv preprint.
[3]
WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarksat-the-media-briefing-on-covid-19,11-March-2020 (Accessed on 03/22/2020).
[4]
Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, etal. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020 Apr; 295 (1): 202-207. Doi: 10.1148/radiol.2020200230. Epub 2020 Feb 4. PubMed PMID: 32017661.
[5]
Kong W and Agarwal P. Chest Imaging Appearance of COVID-19 Infection. Radiology Cardiothoracic Imaging 2020 February 13 (published online), doi: 10.1148/ryct.2020200028.
[6]
Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, etal. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020 Feb 20: 200463. doi: 10.1148/radiol.2020200463. [Epub ahead of print] PubMed PMID: 32077789.
[7]
Pan F, Ye T, Sun P, Gui S, Liang B, Li L, etal. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology. 2020 Feb 13: 200370. doi: 10.1148/radiol.2020200370. [Epub ahead of print] PubMed PMID: 32053470.
[8]
Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, Pan I, Shi LB, Wang DC, etal. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020 Mar 10: 200823. doi: 10.1148/radiol.2020200823. [Epub ahead of print] PubMed PMID: 32155105.
[9]
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol. 2020 Mar 14: 1-7. doi: 10.2214/AJR.20.23034. [Epub ahead of print] PubMed PMID: 32174129.
[10]
Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for radiologists on COVID-19: an update radiology scientific expert panel. Radiology. 2020295 (1); 16–17.
[11]
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30086-4.
[12]
Lee EYP, NgMY, Khong PL. COVID-19 pneumonia: what has CT taught us. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30134-1.
[13]
Qin C, Liu F, Yen TC, Lan X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging. 2020. https://doi.org/10.1007/s00259-020-04734-w.
[14]
Capitanio S, Nordin AJ, Noraini AR, Rossetti C. PET/CT in non-oncological lung diseases: current applications and future perspectives. Eur Respir Rev. 2016; 25: 247–58.
[15]
Jones HA, Marino PS, Shakur BH, Morrell NW. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J. 2003; 21: 567–73.
[16]
Albano D, Bertagna F, Bertoli M, Bosio G, Lucchini S, Motta F, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med 2020; 61: 632–6pp. doi: https://doi.org/10.2967/jnumed.120.246256.
[17]
Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, Zeng B, Li Z, Li X, Li H, Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? European Journal of Radiology (2020), doi: https://doi.org/10.1016/j.ejrad.2020.108961.
[18]
Boom Ting Kung A. An Update on the Role of 18F-FDG-PET/CT in Major Infectious and Inflammatory Diseases. [online] PubMed Central 2020; Accessed 8 May 2020.
[19]
Deng Y, Lei L, Chen Y, Zhang W. The potential added value of FDG PET/CT for COVID-19 pneumonia. Eur J Nucl Med Mol Imaging 2020; 47: 1634–5. doi: https://doi.org/10.1007/s00259-020-04767-115.
[20]
McDermott S, Kilcoyne A, Wang Y, Scott JA, Halpern EF, Ackman JB. Comparison of the 18F-FDG avidity at PET of benign and malignant pure ground-glass opacities: a paradox? Clin Radiol 2019; 74: 187–95. doi: https://doi.org/10.1016/j.Card. 2018. 12. 009.
[21]
Qin C, Liu F, Yen T-C, Lan X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging 2020; 47: 1281–6pp. doi: https://doi.org/10.1007/s00259- 020- 04734-w.
[22]
Setti L, Kirienko M, Dalto SC, Bonacina M, Bombardieri E. Fdg-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients. Eur J Nucl Med Mol Imaging 2020; 47: 1649–56. doi: https://doi.org/10.1007/s00259-020-04819-6.
Browse journals by subject